News

Fixing Risk Capital Gender Inequality

The issue of gender equality in the business world is not a new one but in recent times we have started to see constructive debate gaining traction. While it is sadly still not uncommon to hear stories of successful, qualified women being paid less or being overlooked for promotions, such cases are now at least being called out and given prominence rather than swept under the carpet and accepted as the norm.

How To Maximise Shareholder Value

Julian Costley is a partner of Heaton Camillo, the investment and advisory firm that brings angel investors together with entrepreneurs.

CroíValve Secures €4M in Additional Funding to Initiate Clinical Trials

HBAN investors have contributed towards €4 million in additional financing that has been secured by 

The Front Runner Innovation Challenge

On the 17th of September, 500 professionals working in the business of sport will gather at Dublin’s Aviva Stadium for One-Zero's SportsTech conference to learn, network and help shape the future. A lineup of 40+ international speakers will address an audience of ‘change-makers’, delivering world-class insights across four key sectors and stages.

Investment Puts Phone Tracking Tech Firm in the Driving Seat

Downpatrick-based software company Bluesona has received a six-figure investment from Co-Fund II and the Halo Business Angel Network (HBAN) to further develop the firm’s product offering.

Seraf Toolbox: Modeling Tool for an Early Stage Investment Portfolio

One of the biggest challenges faced by early stage investors is to assemble a portfolio of investments that in aggregate return more than 2 times the original amount invested in the total portfolio. In the language of Venture Capital, the goal of a successful early stage investor is to achieve a Distributed to Paid-In (DPI) ratio greater than 2X. In other words, for every dollar you invest in your portfolio, you want to get two dollars back over time. And, if you want to be one of the top decile early stage investors, you want to shoot for a DPI of 3X or greater to be one of the top decile early stage investors, you want to shoot for a DPI of 3X or greater.

HBAN backed Phorest scoops major European angel investment award

HBAN, the all-island organisation responsible for the promotion of business angel investment and a joint initiative between Enterprise Ireland, InterTradeIreland and Invest Northern Ireland, today announces that its winning streak at the European Business Angels Network (EBAN) annual congress has continued. Phorest, the HBAN-backed salon software company, was named most successful business financed by early stage investors at this year’s event in Helsinki.

HBAN London Syndicate meets on 20th June

Are you an investor and in London on June 20th? If so, join us at the HBAN London Syndicate to see some of the best investment opportunities from the island of Ireland. Did you know the HBAN London Syndicate invested €700k into 5 companies within the first 9 months? This active group of investors welcomes new members at their next meeting on 20th of June in London.                  The HBAN London Syndicate is a group of likeminded individuals seeking qualified deal flow with a UK focus from the island of Ireland. The syndicate usually co-invests alongside a local Irish lead investor, with due diligence documents available.

Angel Investing Exits: The Good, the Bad, and the Ugly

After a year or two down the path of building a diversified portfolio of angel investments, many individual angels are faced with some uncertainty about their path forward. The questions on many experienced angels’ minds are “Will I make a good enough return on my angel investments to justify the risk? Should I continue to invest?”  

Deciphex Finalise €2.3m Equity Fundraising to Accelerate Commercialisation and Research Programs

Deciphex an Irish based technology player, applying AI in pathology, has announced the conclusion of a €2.3m equity funding and convertible debt conversion event which will empower the company to accelerate its research and development in Artificial Intelligence and ramp up market entry in preclincial/toxicologic digital pathology.
Page 3 of 28